Dr. Agarwal’s Health Care Limited has released its Monitoring Agency Report for the quarter ended March 31, 2026. The report confirms that the utilization of proceeds from the company’s Initial Public Offer remains consistent with the original objects disclosed in the prospectus. There are no deviations observed in the deployment of funds, and all project implementations are currently on schedule for the identified growth and operational objectives.
Proceeds Utilization Overview
The Monitoring Agency, ICRA Limited, has verified the utilization of INR 300 crore in gross IPO proceeds as of the quarter ended March 31, 2026. The assessment confirms that the company has adhered to its stated financial goals. The monitoring process involved a review of peer-reviewed CA certificates and bank statements for escrow and proceeds accounts.
Financial Progress Highlights
As of the end of the quarter, the company has utilized a total of INR 276.859 crore. The breakdown of fund allocation includes:
- Repayment/prepayment of borrowings: INR 195 crore fully utilized.
- General corporate purposes: INR 69.209 crore utilized out of the allocated INR 77.466 crore.
- Issue-related expenses: INR 12.650 crore utilized.
Strategic Deployment of General Corporate Funds
A significant portion of the general corporate purpose funds has been strategically invested in business expansion and infrastructure. Key expenditures include INR 25.279 crore for the purchase of medical equipment and consumables, INR 23.109 crore for deferred payments related to acquisitions, and INR 16.528 crore for interior projects and fixtures. The remaining unutilized funds are currently deployed in low-risk interest-bearing instruments, including fixed deposits with various financial institutions.
Operational Status
The company reports that all identified objects are proceeding on schedule according to the original timelines stipulated in the offer document. No adverse events have impacted the viability of the projects, and the board has confirmed that there are no deviations or material changes to the financial planning for these objectives.
Source: BSE
